Loading…

MEAT SCIENCE AND MUSCLE BIOLOGY SYMPOSIUM--implant and beta agonist impacts on beef palatability

The use of anabolic implants has a long-standing place in the cattle feeding industry, due to their positive impact on growth performance and subsequent profitability. However, implants can have adverse effects on carcass quality, shear force, and eating quality depending on the dose and frequency,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of animal science 2014-01, Vol.92 (1), p.10-20
Main Authors: Garmyn, A J, Miller, M F
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 20
container_issue 1
container_start_page 10
container_title Journal of animal science
container_volume 92
creator Garmyn, A J
Miller, M F
description The use of anabolic implants has a long-standing place in the cattle feeding industry, due to their positive impact on growth performance and subsequent profitability. However, implants can have adverse effects on carcass quality, shear force, and eating quality depending on the dose and frequency, or what some refer to as the aggressiveness of the implant regimen administered. Within the past decade, a new class of growth promotants, known as β-adrenergic agonists (βAA), has emerged in the beef feeding industry in the United States. Currently, 2 have gained U.S. Food and Drug Administration approval for use in beef finishing diets to improve performance and carcass yields. Much like anabolic implants, these repartitioning agents can have negative effects on Warner-Bratzler shear force (WBSF), but the differences do not necessarily translate directly to consumer responses for palatability and acceptance in some instances, especially when tenderness is managed through proper postmortem aging. As researchers continued to investigate the mechanisms responsible for the impact of βAA, inevitably this led to consideration of the interaction between βAA and anabolic implants. Early work combining zilpaterol hydrochloride (ZH) with anabolic implants improved performance, carcass yield, and meat yield with additive negative effects on WBSF. Similar results were produced when pairing ZH with anabolic steroids equipped with various release patterns. As with any tool, the key to success is proper management. Certain cattle populations may be better suited to receive growth promotants such as implants and βAA, and postmortem management of subprimal cuts becomes vital when producers take more aggressive approaches to improve performance and yield. The objective of this review is to overview research findings related to the impact of growth promotant technologies on beef palatability, focusing specifically on the role of implants and βAA on carcass quality, beef tenderness, and consumer responses for meat palatability.
doi_str_mv 10.2527/jas.2013-7097
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1490724700</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1490724700</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-ee8d990cb4765e5e41c15b7be7dcb72a538aa10b213e0e4ee946ff7bd3ef75fa3</originalsourceid><addsrcrecordid>eNo1kD1PwzAYhC0kREthZEUeWVz8GTdjCQEiNS1S2qFTsJM3KFW-qN2h_55IlOmku0en0yH0wOicK66fD8bNOWWCaBrqKzRliisiWCAm6Na5A6WMq1DdoAmXTC1EIKfoK42XW5xFSbyOYrxcv-J0l0WrGL8km9XmfY-zffq5yZJdSkjdDo3pPDZdiS14g81339XO4zEwhXe470YfKjyYxnhj66b25zt0XZnGwf1FZ2j3Fm-jDzK2J9FyRQbOmCcAizIMaWGlDhQokKxgymoLuiys5kaJhTGMWs4EUJAAoQyqSttSQKVVZcQMPf31Dsf-5wTO523tCmjGxdCfXM5kSDWXmtIRfbygJ9tCmQ_HujXHc_7_ivgFfTtfiQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490724700</pqid></control><display><type>article</type><title>MEAT SCIENCE AND MUSCLE BIOLOGY SYMPOSIUM--implant and beta agonist impacts on beef palatability</title><source>Oxford Journals Online</source><creator>Garmyn, A J ; Miller, M F</creator><creatorcontrib>Garmyn, A J ; Miller, M F</creatorcontrib><description>The use of anabolic implants has a long-standing place in the cattle feeding industry, due to their positive impact on growth performance and subsequent profitability. However, implants can have adverse effects on carcass quality, shear force, and eating quality depending on the dose and frequency, or what some refer to as the aggressiveness of the implant regimen administered. Within the past decade, a new class of growth promotants, known as β-adrenergic agonists (βAA), has emerged in the beef feeding industry in the United States. Currently, 2 have gained U.S. Food and Drug Administration approval for use in beef finishing diets to improve performance and carcass yields. Much like anabolic implants, these repartitioning agents can have negative effects on Warner-Bratzler shear force (WBSF), but the differences do not necessarily translate directly to consumer responses for palatability and acceptance in some instances, especially when tenderness is managed through proper postmortem aging. As researchers continued to investigate the mechanisms responsible for the impact of βAA, inevitably this led to consideration of the interaction between βAA and anabolic implants. Early work combining zilpaterol hydrochloride (ZH) with anabolic implants improved performance, carcass yield, and meat yield with additive negative effects on WBSF. Similar results were produced when pairing ZH with anabolic steroids equipped with various release patterns. As with any tool, the key to success is proper management. Certain cattle populations may be better suited to receive growth promotants such as implants and βAA, and postmortem management of subprimal cuts becomes vital when producers take more aggressive approaches to improve performance and yield. The objective of this review is to overview research findings related to the impact of growth promotant technologies on beef palatability, focusing specifically on the role of implants and βAA on carcass quality, beef tenderness, and consumer responses for meat palatability.</description><identifier>EISSN: 1525-3163</identifier><identifier>DOI: 10.2527/jas.2013-7097</identifier><identifier>PMID: 24158364</identifier><language>eng</language><publisher>United States</publisher><subject>Adrenergic beta-Agonists - pharmacology ; Anabolic Agents - pharmacology ; Animals ; Cattle - physiology ; Drug Implants - pharmacology ; Female ; Male ; Meat - analysis ; Phenethylamines - pharmacology ; Trimethylsilyl Compounds - pharmacology</subject><ispartof>Journal of animal science, 2014-01, Vol.92 (1), p.10-20</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24158364$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Garmyn, A J</creatorcontrib><creatorcontrib>Miller, M F</creatorcontrib><title>MEAT SCIENCE AND MUSCLE BIOLOGY SYMPOSIUM--implant and beta agonist impacts on beef palatability</title><title>Journal of animal science</title><addtitle>J Anim Sci</addtitle><description>The use of anabolic implants has a long-standing place in the cattle feeding industry, due to their positive impact on growth performance and subsequent profitability. However, implants can have adverse effects on carcass quality, shear force, and eating quality depending on the dose and frequency, or what some refer to as the aggressiveness of the implant regimen administered. Within the past decade, a new class of growth promotants, known as β-adrenergic agonists (βAA), has emerged in the beef feeding industry in the United States. Currently, 2 have gained U.S. Food and Drug Administration approval for use in beef finishing diets to improve performance and carcass yields. Much like anabolic implants, these repartitioning agents can have negative effects on Warner-Bratzler shear force (WBSF), but the differences do not necessarily translate directly to consumer responses for palatability and acceptance in some instances, especially when tenderness is managed through proper postmortem aging. As researchers continued to investigate the mechanisms responsible for the impact of βAA, inevitably this led to consideration of the interaction between βAA and anabolic implants. Early work combining zilpaterol hydrochloride (ZH) with anabolic implants improved performance, carcass yield, and meat yield with additive negative effects on WBSF. Similar results were produced when pairing ZH with anabolic steroids equipped with various release patterns. As with any tool, the key to success is proper management. Certain cattle populations may be better suited to receive growth promotants such as implants and βAA, and postmortem management of subprimal cuts becomes vital when producers take more aggressive approaches to improve performance and yield. The objective of this review is to overview research findings related to the impact of growth promotant technologies on beef palatability, focusing specifically on the role of implants and βAA on carcass quality, beef tenderness, and consumer responses for meat palatability.</description><subject>Adrenergic beta-Agonists - pharmacology</subject><subject>Anabolic Agents - pharmacology</subject><subject>Animals</subject><subject>Cattle - physiology</subject><subject>Drug Implants - pharmacology</subject><subject>Female</subject><subject>Male</subject><subject>Meat - analysis</subject><subject>Phenethylamines - pharmacology</subject><subject>Trimethylsilyl Compounds - pharmacology</subject><issn>1525-3163</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo1kD1PwzAYhC0kREthZEUeWVz8GTdjCQEiNS1S2qFTsJM3KFW-qN2h_55IlOmku0en0yH0wOicK66fD8bNOWWCaBrqKzRliisiWCAm6Na5A6WMq1DdoAmXTC1EIKfoK42XW5xFSbyOYrxcv-J0l0WrGL8km9XmfY-zffq5yZJdSkjdDo3pPDZdiS14g81339XO4zEwhXe470YfKjyYxnhj66b25zt0XZnGwf1FZ2j3Fm-jDzK2J9FyRQbOmCcAizIMaWGlDhQokKxgymoLuiys5kaJhTGMWs4EUJAAoQyqSttSQKVVZcQMPf31Dsf-5wTO523tCmjGxdCfXM5kSDWXmtIRfbygJ9tCmQ_HujXHc_7_ivgFfTtfiQ</recordid><startdate>201401</startdate><enddate>201401</enddate><creator>Garmyn, A J</creator><creator>Miller, M F</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201401</creationdate><title>MEAT SCIENCE AND MUSCLE BIOLOGY SYMPOSIUM--implant and beta agonist impacts on beef palatability</title><author>Garmyn, A J ; Miller, M F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-ee8d990cb4765e5e41c15b7be7dcb72a538aa10b213e0e4ee946ff7bd3ef75fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adrenergic beta-Agonists - pharmacology</topic><topic>Anabolic Agents - pharmacology</topic><topic>Animals</topic><topic>Cattle - physiology</topic><topic>Drug Implants - pharmacology</topic><topic>Female</topic><topic>Male</topic><topic>Meat - analysis</topic><topic>Phenethylamines - pharmacology</topic><topic>Trimethylsilyl Compounds - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garmyn, A J</creatorcontrib><creatorcontrib>Miller, M F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of animal science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garmyn, A J</au><au>Miller, M F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MEAT SCIENCE AND MUSCLE BIOLOGY SYMPOSIUM--implant and beta agonist impacts on beef palatability</atitle><jtitle>Journal of animal science</jtitle><addtitle>J Anim Sci</addtitle><date>2014-01</date><risdate>2014</risdate><volume>92</volume><issue>1</issue><spage>10</spage><epage>20</epage><pages>10-20</pages><eissn>1525-3163</eissn><abstract>The use of anabolic implants has a long-standing place in the cattle feeding industry, due to their positive impact on growth performance and subsequent profitability. However, implants can have adverse effects on carcass quality, shear force, and eating quality depending on the dose and frequency, or what some refer to as the aggressiveness of the implant regimen administered. Within the past decade, a new class of growth promotants, known as β-adrenergic agonists (βAA), has emerged in the beef feeding industry in the United States. Currently, 2 have gained U.S. Food and Drug Administration approval for use in beef finishing diets to improve performance and carcass yields. Much like anabolic implants, these repartitioning agents can have negative effects on Warner-Bratzler shear force (WBSF), but the differences do not necessarily translate directly to consumer responses for palatability and acceptance in some instances, especially when tenderness is managed through proper postmortem aging. As researchers continued to investigate the mechanisms responsible for the impact of βAA, inevitably this led to consideration of the interaction between βAA and anabolic implants. Early work combining zilpaterol hydrochloride (ZH) with anabolic implants improved performance, carcass yield, and meat yield with additive negative effects on WBSF. Similar results were produced when pairing ZH with anabolic steroids equipped with various release patterns. As with any tool, the key to success is proper management. Certain cattle populations may be better suited to receive growth promotants such as implants and βAA, and postmortem management of subprimal cuts becomes vital when producers take more aggressive approaches to improve performance and yield. The objective of this review is to overview research findings related to the impact of growth promotant technologies on beef palatability, focusing specifically on the role of implants and βAA on carcass quality, beef tenderness, and consumer responses for meat palatability.</abstract><cop>United States</cop><pmid>24158364</pmid><doi>10.2527/jas.2013-7097</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1525-3163
ispartof Journal of animal science, 2014-01, Vol.92 (1), p.10-20
issn 1525-3163
language eng
recordid cdi_proquest_miscellaneous_1490724700
source Oxford Journals Online
subjects Adrenergic beta-Agonists - pharmacology
Anabolic Agents - pharmacology
Animals
Cattle - physiology
Drug Implants - pharmacology
Female
Male
Meat - analysis
Phenethylamines - pharmacology
Trimethylsilyl Compounds - pharmacology
title MEAT SCIENCE AND MUSCLE BIOLOGY SYMPOSIUM--implant and beta agonist impacts on beef palatability
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T18%3A10%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MEAT%20SCIENCE%20AND%20MUSCLE%20BIOLOGY%20SYMPOSIUM--implant%20and%20beta%20agonist%20impacts%20on%20beef%20palatability&rft.jtitle=Journal%20of%20animal%20science&rft.au=Garmyn,%20A%20J&rft.date=2014-01&rft.volume=92&rft.issue=1&rft.spage=10&rft.epage=20&rft.pages=10-20&rft.eissn=1525-3163&rft_id=info:doi/10.2527/jas.2013-7097&rft_dat=%3Cproquest_pubme%3E1490724700%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p211t-ee8d990cb4765e5e41c15b7be7dcb72a538aa10b213e0e4ee946ff7bd3ef75fa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1490724700&rft_id=info:pmid/24158364&rfr_iscdi=true